Biblio Discovery — Demo Discovery Service

14 results for "Joban Vaishnav"

Showing 1–14 · 0.31 seconds · RSS

  1. Journal Article

    Transthyretin Amyloid Cardiomyopathy in Women: Epidemiology, Diagnostic Delay, and Clinical Implications

    Avni Madhani; Bhavya Ancha; Kevin M. Alexander et al.

    Cardiology and Therapy, Vol. 15 No. 3 · 2026 · English · DOAJ Scopus

    Abstract Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure, resulting from the deposition of misfolded transthyretin protein in the myocardium. While historically considered to be a male-predominant disease, an increasing number of studies have shown that…

  2. Journal Article

    Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis

    Paul J. Scheel; Monica Mukherjee; Allison G. Hays et al.

    Frontiers in Cardiovascular Medicine, Vol. 9 · 2022 · English · DOAJ Scopus

    Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy resulting from deposition of misfolded immunoglobulin light chains (AL-CA) or transthyretin (ATTR-CA) proteins in the myocardium. Survival varies between the different subtypes of amyloidosis and degree of cardiac involvement, but accurate…

  3. Journal Article

    Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction

    Eunice Yang; Joban Vaishnav; Evelyn Song et al.

    ESC Heart Failure, Vol. 9 No. 5 · 2022 · English · DOAJ Scopus

    Abstract Aims Atrial fibrillation (AF) is a common comorbid condition in heart failure with preserved ejection fraction (HFpEF). The effect of AF on heart failure (HF) exacerbation in HFpEF has not been well described. This study investigated how AF modifies the clinical trajectory of HFpEF…

  4. Journal Article Full text

    Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction

    Virginia Shalkey Hahn; Hildur Knútsdóttir; Xin Luo et al.

    Circulation · 2020 · English · OpenAlex Scopus

    BACKGROUND: Heart failure (HF) with preserved ejection fraction (HFpEF) constitutes half of all HF but lacks effective therapy. Understanding of its myocardial biology remains limited because of a paucity of heart tissue molecular analysis. METHODS: We performed RNA sequencing on right ventricular…

  5. Journal Article

    Highest Obesity Category Associated With Largest Decrease in N‐Terminal Pro‐B‐Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction

    Joban Vaishnav; Jessica E. Chasler; Yizhen J. Lee et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 9 No. 15 · 2020 · English · DOAJ Scopus

    Background Heart failure with preserved ejection fraction (HFpEF) constitutes half of hospitalized heart failure cases and is commonly associated with obesity. The role of natriuretic peptide levels in hospitalized obese patients with HFpEF, however, is not well defined. We sought to evaluate…

  6. Journal Article

    Anomalous Origin of the Right Coronary Artery Causing Myocardial Ischemia: A Case for a Multimodality Imaging Approach

    Fatimah A. Alkhunaizi; Karan Kapoor; Vincent Pallazola et al.

    Case Reports in Cardiology, Vol. 2021 · 2021 · English · DOAJ Scopus

    A 46-year-old man was admitted with non-ST elevation myocardial infarction and newly diagnosed acutely decompensated heart failure. Echocardiogram demonstrated left ventricular ejection fraction of 30% with basal inferior and inferolateral akinesis. Coronary angiography showed mild diffuse coronary…

  7. Journal Article

    Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis

    Abhishek Gami, MD; John Woller, MD; Paul Scheel, MD et al.

    JACC: Case Reports, Vol. 29 No. 7 · 2024 · English · DOAJ Scopus

    Although most patients with cardiac amyloidosis are diagnosed with either light chain (AL) or transthyretin (ATTR) disease, coexisting amyloid subtypes can occur. We present three cases of coexisting AL and ATTR cardiac amyloidosis and demonstrate the importance of clinical history and…

  8. Journal Article

    Crossing the Bridge to Heart Transplantation

    Joban Vaishnav, MD; Steven Hsu, MD; Kavita Sharma, MD et al.

    JACC: Case Reports, Vol. 2 No. 2 · 2020 · English · DOAJ Scopus

    We report the first case of a patient with a durable left ventricular assist device admitted with cardiogenic shock and managed with biventricular Impella support as a successful bridge to heart transplantation. (Level of Difficulty: Advanced.)

  9. Journal Article

    Systemic Oxalosis Mimicking Transthyretin Amyloid Cardiomyopathy

    Bhavya Ancha, MD; Virginia Hahn, MD; Charles Steenbergen, Jr., MD, PhD et al.

    JACC: Case Reports, Vol. 31 No. 38 · 2026 · English · DOAJ Scopus

    Background: Technetium-99m pyrophosphate (Tc-99m PYP) scintigraphy is a noninvasive imaging modality in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM), though false positive results may result in adverse clinical outcomes. Case Summary: A 53-year-old man with a history of heart…

  10. Journal Article

    Dual-Organ Transplantation in a Woman With Right Ventricular Failure Secondary to Arrhythmogenic Right Ventricular Cardiomyopathy

    Sabra C. Lewsey, MD, MPH; Kavita Sharma, MD; Ahmet Kilic, MD et al.

    JACC: Case Reports, Vol. 2 No. 1 · 2020 · English · DOAJ Scopus

    We report a case of a woman with arrhythmogenic right ventricular cardiomyopathy (ARVC) who presented with severe right-sided heart failure and cardiac cirrhosis that mandated heart-liver transplantation. This case highlights an emerging sex-based difference in ARVC where female sex is associated…

  11. Journal Article

    Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience

    Paul J. Scheel III; Katherine Giuliano; Crystal Tichnell et al.

    ESC Heart Failure, Vol. 9 No. 2 · 2022 · English · DOAJ Scopus

    Abstract Aims End‐stage heart failure necessitating evaluation for heart transplantation is increasingly recognized in arrhythmogenic right ventricular cardiomyopathy (ARVC). These patients present unique challenges in pre‐transplant and peri‐transplant management given their predominantly right…

  12. Journal Article

    Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction

    Radu Tanacli, MD, DPhil; Rishi K. Trivedi, MD, PhD; Masih Tajdini, MD et al.

    JACC: Advances, Vol. 5 No. 3 · 2026 · English · DOAJ Scopus

    Background: Frailty reflects multisystem physiologic dysfunction and is linked to adverse outcomes. Its prevalence and prognostic importance in ambulatory heart failure with preserved ejection fraction (HFpEF) are unclear. Objectives: The purpose of this study was to define clinical, hemodynamic…

  13. Journal Article

    ATTR-CM in Patients With Clinically Significant Plasma Cell Dyscrasias

    Bhavya Ancha, MD; Emily Brown, MGC, CGC; Mark Ranek, PhD et al.

    JACC: Case Reports, Vol. 31 No. 38 · 2026 · English · DOAJ Scopus

    Background: Suspicion and diagnosis of transthyretin cardiac amyloidosis (ATTR-CM) in patients with clinically significant plasma cell disorders is challenging. Timely identification of both light chain (AL) and ATTR-CM is essential for optimizing patient outcomes. Case Summary: We report 6…